republic-os/legislation/us/states/va/2020/hb-1654.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Schedule VI controlled substances and hypodermic syringes and needles; limited-use license.	Schedule VI controlled substances; hypodermic syringes and needles; limited-use license. Allows the Board of Pharmacy to issue a limited-use license for the purpose of dispensing Schedule VI controlled substances, excluding the combination of misoprostol and methotrexate, and hypodermic syringes and needles for the administration of prescribed controlled substances to a doctor of medicine, osteopathic medicine, or podiatry, a nurse practitioner, or a physician assistant, provided that such limited-use licensee is practicing at a nonprofit facility. The bill requires such nonprofit facilities to obtain a limited-use permit from the Board and comply with regulations for such a permit. This bill directs the Board of Pharmacy to adopt emergency regulations to implement the provisions of the bill. This bill is identical to SB 1074.	us/states/va	Virginia General Assembly	2020	HB 1654	Virginia HB 1654 (2020)	bill		enacted	Dan I. Helmer	3	31	7	2020-01-17	2020-04-02	openstates	ocd-bill/1ac90918-a0c4-417d-8c25-bfd21acd8d50	https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+HB1654	da5b9840cd2d2d34de60543a5c26bac573572a6dbc6b60d9ddf457d3622b233a	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-va

Virginia HB 1654 (2020) — Schedule VI controlled substances and hypodermic syringes and needles; limited-use license.

Schedule VI controlled substances; hypodermic syringes and needles; limited-use license. Allows the Board of Pharmacy to issue a limited-use license for the purpose of dispensing Schedule VI controlled substances, excluding the combination of misoprostol and methotrexate, and hypodermic syringes and needles for the administration of prescribed controlled substances to a doctor of medicine, osteopathic medicine, or podiatry, a nurse practitioner, or a physician assistant, provided that such limited-use licensee is practicing at a nonprofit facility. The bill requires such nonprofit facilities to obtain a limited-use permit from the Board and comply with regulations for such a permit. This bill directs the Board of Pharmacy to adopt emergency regulations to implement the provisions of the bill. This bill is identical to SB 1074.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Acts of Assembly Chapter text (CHAP0609) (committee substitute) — source
2. Bill text as passed House and Senate (HB1654ER) (committee substitute) — source
3. Impact statement from DPB (HB1654) (committee substitute) — source

Votes

• Constitutional reading dispensed (37-Y 0-N) — 37–0 (pass) · upper
• Reported from Education and Health with amendment (14-Y 0-N) — 14–0 (pass) · upper
• VOTE: Adoption (96-Y 1-N) — 95–1 (pass) · lower
• VOTE: Block Vote Passage (100-Y 0-N) — 99–0 (pass) · lower
• Subcommittee recommends reporting (4-Y 1-N) — 4–1 (pass) · lower
• Reported from Health, Welfare and Institutions (22-Y 0-N) — 22–0 (pass) · lower
• Passed Senate with amendment (40-Y 0-N) — 40–0 (pass) · upper

Sponsors

• Dan I. Helmer — primary (person)
• Hala S. Ayala — cosponsor (person)
• Kathy K.L. Tran — cosponsor (person)
• Richard C. "Rip" Sullivan, Jr. — cosponsor (person)
• Rodney T. Willett — cosponsor (person)
• Suhas Subramanyam — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2020-01-17 Presented and ordered printed 20105315D introduction
• 2020-01-17 Referred to Committee on Health, Welfare and Institutions referral-committee
• 2020-01-27 Assigned HWI sub: Health Professions referral-committee
• 2020-01-28 Impact statement from DPB (HB1654)
• 2020-01-29 Subcommittee recommends reporting (4-Y 1-N)
• 2020-02-04 Reported from Health, Welfare and Institutions (22-Y 0-N) committee-passage
• 2020-02-05 Read first time reading-1
• 2020-02-06 Read second time and engrossed reading-2
• 2020-02-07 Read third time and passed House BLOCK VOTE (100-Y 0-N) passage, reading-3
• 2020-02-07 VOTE: Block Vote Passage (100-Y 0-N)
• 2020-02-10 Constitutional reading dispensed
• 2020-02-10 Referred to Committee on Education and Health referral-committee
• 2020-02-27 Reported from Education and Health with amendment (14-Y 0-N) committee-passage
• 2020-02-28 Constitutional reading dispensed (37-Y 0-N)
• 2020-03-02 Read third time reading-3
• 2020-03-02 Reading of amendment waived
• 2020-03-02 Committee amendment agreed to
• 2020-03-02 Passed by for the day
• 2020-03-03 Read third time reading-3
• 2020-03-03 Engrossed by Senate as amended
• 2020-03-03 Passed Senate with amendment (40-Y 0-N) passage
• 2020-03-04 Placed on Calendar
• 2020-03-04 Senate amendment agreed to by House (96-Y 1-N)
• 2020-03-04 VOTE: Adoption (96-Y 1-N)
• 2020-03-07 Enrolled
• 2020-03-07 Signed by President
• 2020-03-08 Signed by Speaker
• 2020-03-09 Impact statement from DPB (HB1654ER)
• 2020-03-12 Enrolled Bill communicated to Governor on March 12, 2020
• 2020-03-12 Governor's Action Deadline 11:59 p.m., April 11, 2020
• 2020-04-02 Approved by Governor-Chapter 609 (effective 7/1/20) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/1ac90918-a0c4-417d-8c25-bfd21acd8d50. Confidence: reported (aggregated from official Virginia legislature records).